Literature DB >> 34546711

homeRNA: A Self-Sampling Kit for the Collection of Peripheral Blood and Stabilization of RNA.

Amanda J Haack1,2, Fang Yun Lim1, Dakota S Kennedy1, John H Day1, Karen N Adams3, Jing J Lee1, Erwin Berthier1, Ashleigh B Theberge1,4.   

Abstract

Gene expression analysis (e.g., targeted gene panels and transcriptomics) from whole blood can elucidate mechanisms of the immune function and aid in the discovery of biomarkers. Conventional venipuncture offers only a small snapshot of our broad immune landscape as immune responses may occur outside of the time and location parameters available for conventional venipuncture. A self-operated method that enables flexible sampling of liquid whole blood coupled with immediate stabilization of cellular RNA is instrumental in facilitating capture and preservation of acute or transient immune fluxes. To this end, we developed homeRNA, a kit for self-collection of peripheral blood (∼0.5 mL) and immediate stabilization of cellular RNA, using the Tasso-SST blood collection device with a specially designed stabilizer tube containing RNAlater. To assess the feasibility of homeRNA for self-collection and stabilization of whole blood RNA, we conducted a pilot study (n = 47 participants) in which we sent homeRNA to participants aged 21-69, located across 10 US states (94% successful blood collections, n = 61/65). Among participants who successfully collected blood, 93% reported no or minimal pain/discomfort using the kit (n = 39/42), and 79% reported very easy/somewhat easy stabilization protocol (n = 33/42). Total RNA yield from the stabilized samples ranged between 0.20 and 5.99 μg (mean = 1.51 μg), and all but one RNA integrity number values were above 7.0 (mean = 8.1), indicating limited RNA degradation. The results from this study demonstrate the self-collection and RNA stabilization of whole blood with homeRNA by participants themselves in their own home.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34546711      PMCID: PMC9134895          DOI: 10.1021/acs.analchem.1c02008

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   8.008


  33 in total

1.  Assessment of sample collection and storage methods for multicenter immunologic research in children.

Authors:  Loren A Matheson; Trang T Duong; Alan M Rosenberg; Rae S M Yeung
Journal:  J Immunol Methods       Date:  2008-09-02       Impact factor: 2.303

2.  Microneedle-based device for the one-step painless collection of capillary blood samples.

Authors:  Timothy M Blicharz; Ping Gong; Bernard M Bunner; Larry L Chu; Kaela M Leonard; Jessica A Wakefield; Richard E Williams; Maisam Dadgar; Carlo A Tagliabue; Ragheb El Khaja; Stephanie L Marlin; Ramin Haghgooie; Shawn P Davis; Donald E Chickering; Howard Bernstein
Journal:  Nat Biomed Eng       Date:  2018-02-19       Impact factor: 25.671

3.  Feasibility of a mail-in, self-administered dried blood spot collection method in national, population-based alcohol surveys in the United States.

Authors:  Priscilla Martinez; Sarah E Zemore
Journal:  Addiction       Date:  2019-04-29       Impact factor: 6.526

4.  Therapeutic drug monitoring in dried blood spots using liquid microjunction surface sampling and high resolution mass spectrometry.

Authors:  Tanja Gaissmaier; Markus Siebenhaar; Vanya Todorova; Volker Hüllen; Carsten Hopf
Journal:  Analyst       Date:  2016-01-13       Impact factor: 4.616

5.  Dried-blood spot screening for cystic fibrosis in the newborn.

Authors:  J R Crossley; R B Elliott; P A Smith
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

6.  Enzymatic and Chemical-Based Methods to Inactivate Endogenous Blood Ribonucleases for Nucleic Acid Diagnostics.

Authors:  Andrew T Bender; Benjamin P Sullivan; Lorraine Lillis; Jonathan D Posner
Journal:  J Mol Diagn       Date:  2020-05-22       Impact factor: 5.568

7.  Genome-Wide Profiling of RNA from Dried Blood Spots: Convergence with Bioinformatic Results Derived from Whole Venous Blood and Peripheral Blood Mononuclear Cells.

Authors:  Thomas W McDade; Kharah M Ross; Ruby L Fried; Jesusa M G Arevalo; Jeffrey Ma; Gregory E Miller; Steve W Cole
Journal:  Biodemography Soc Biol       Date:  2016

8.  Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities.

Authors:  Sarah M Lofgren; Anne B Morrissey; Caroline C Chevallier; Anangisye I Malabeja; Sally Edmonds; Ben Amos; David J Sifuna; Lorenz von Seidlein; Werner Schimana; Wendy S Stevens; John A Bartlett; John A Crump
Journal:  AIDS       Date:  2009-11-27       Impact factor: 4.177

9.  Low-cost, low-input RNA-seq protocols perform nearly as well as high-input protocols.

Authors:  Peter A Combs; Michael B Eisen
Journal:  PeerJ       Date:  2015-03-26       Impact factor: 2.984

10.  DV200 Index for Assessing RNA Integrity in Next-Generation Sequencing.

Authors:  Takehiro Matsubara; Junichi Soh; Mizuki Morita; Takahiro Uwabo; Shuta Tomida; Toshiyoshi Fujiwara; Susumu Kanazawa; Shinichi Toyooka; Akira Hirasawa
Journal:  Biomed Res Int       Date:  2020-02-25       Impact factor: 3.411

View more
  2 in total

1.  Assessing the use of a micro-sampling device for measuring blood protein levels in healthy subjects and COVID-19 patients.

Authors:  Joost Brandsma; Josh G Chenoweth; Melissa K Gregory; Subramaniam Krishnan; Paul W Blair; Deborah A Striegel; Rittal Mehta; Kevin L Schully; J Stephen Dumler; Cdr Cynthia S Sikorski; Kelsey O'Connor; Susan A Reichert-Scrivner; Carmen M Paguirigan; Catherine F T Uyehara; Col Viseth Ngauy; Christopher A Myers; Danielle V Clark
Journal:  PLoS One       Date:  2022-08-10       Impact factor: 3.752

2.  At-home blood collection and stabilization in high temperature climates using homeRNA.

Authors:  Lauren G Brown; Amanda J Haack; Dakota S Kennedy; Karen N Adams; Jennifer E Stolarczuk; Meg G Takezawa; Erwin Berthier; Sanitta Thongpang; Fang Yun Lim; Damien Chaussabel; Mathieu Garand; Ashleigh B Theberge
Journal:  Front Digit Health       Date:  2022-08-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.